Kosaki et al. reported that patients who developed AKI in the early phase of MI had higher levels of C-reactive protein (CRP), suggesting that an inflammatory response in the cardiorenal axis might be a more significant contributor to AKI and long-term adverse events [60]. The gene discussed is CRP; the disease is myocardial infarction.